ABBVIE INC (4AB.DE) Fundamental Analysis & Valuation
FRA:4AB • US00287Y1091
Current stock price
180.25 EUR
+5.4 (+3.09%)
Last:
This 4AB.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. 4AB.DE Profitability Analysis
1.1 Basic Checks
- 4AB had positive earnings in the past year.
- In the past year 4AB had a positive cash flow from operations.
- In the past 5 years 4AB has always been profitable.
- Each year in the past 5 years 4AB had a positive operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of 3.12%, 4AB is in the better half of the industry, outperforming 75.95% of the companies in the same industry.
- Looking at the Return On Invested Capital, with a value of 14.42%, 4AB belongs to the top of the industry, outperforming 93.67% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for 4AB is in line with the industry average of 11.35%.
- The last Return On Invested Capital (14.42%) for 4AB is above the 3 year average (12.12%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.12% | ||
| ROE | N/A | ||
| ROIC | 14.42% |
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
1.3 Margins
- 4AB has a better Profit Margin (6.84%) than 75.95% of its industry peers.
- 4AB's Profit Margin has declined in the last couple of years.
- Looking at the Operating Margin, with a value of 34.23%, 4AB belongs to the top of the industry, outperforming 91.14% of the companies in the same industry.
- 4AB's Operating Margin has improved in the last couple of years.
- 4AB has a better Gross Margin (71.62%) than 62.03% of its industry peers.
- 4AB's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 34.23% | ||
| PM (TTM) | 6.84% | ||
| GM | 71.62% |
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
2. 4AB.DE Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 4AB is creating some value.
- 4AB has about the same amout of shares outstanding than it did 1 year ago.
- 4AB has about the same amout of shares outstanding than it did 5 years ago.
- Compared to 1 year ago, 4AB has a worse debt to assets ratio.
2.2 Solvency
- 4AB has an Altman-Z score of 2.25. This is not the best score and indicates that 4AB is in the grey zone with still only limited risk for bankruptcy at the moment.
- With a Altman-Z score value of 2.25, 4AB perfoms like the industry average, outperforming 56.96% of the companies in the same industry.
- 4AB has a debt to FCF ratio of 3.79. This is a good value and a sign of high solvency as 4AB would need 3.79 years to pay back of all of its debts.
- 4AB's Debt to FCF ratio of 3.79 is amongst the best of the industry. 4AB outperforms 84.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.79 | ||
| Altman-Z | 2.25 |
ROIC/WACC1.67
WACC8.64%
2.3 Liquidity
- A Current Ratio of 0.67 indicates that 4AB may have some problems paying its short term obligations.
- 4AB's Current ratio of 0.67 is on the low side compared to the rest of the industry. 4AB is outperformed by 79.75% of its industry peers.
- 4AB has a Quick Ratio of 0.67. This is a bad value and indicates that 4AB is not financially healthy enough and could expect problems in meeting its short term obligations.
- 4AB has a worse Quick ratio (0.56) than 81.01% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.56 |
3. 4AB.DE Growth Analysis
3.1 Past
- The earnings per share for 4AB have decreased by -1.19% in the last year.
- The Earnings Per Share has been decreasing by -0.99% on average over the past years.
- The Revenue has grown by 8.57% in the past year. This is quite good.
- The Revenue has been growing slightly by 5.95% on average over the past years.
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%
3.2 Future
- 4AB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.08% yearly.
- 4AB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.43% yearly.
EPS Next Y48.4%
EPS Next 2Y28.14%
EPS Next 3Y22.01%
EPS Next 5Y15.08%
Revenue Next Year10.06%
Revenue Next 2Y9.09%
Revenue Next 3Y8.46%
Revenue Next 5Y6.43%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. 4AB.DE Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 20.84, 4AB is valued on the expensive side.
- Based on the Price/Earnings ratio, 4AB is valued cheaply inside the industry as 83.54% of the companies are valued more expensively.
- When comparing the Price/Earnings ratio of 4AB to the average of the S&P500 Index (26.91), we can say 4AB is valued slightly cheaper.
- 4AB is valuated correctly with a Price/Forward Earnings ratio of 14.04.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of 4AB indicates a rather cheap valuation: 4AB is cheaper than 94.94% of the companies listed in the same industry.
- 4AB's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.69.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.84 | ||
| Fwd PE | 14.04 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, 4AB is valued cheaper than 84.81% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, 4AB is valued cheaper than 89.87% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.67 | ||
| EV/EBITDA | 14.34 |
4.3 Compensation for Growth
- 4AB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- 4AB has a very decent profitability rating, which may justify a higher PE ratio.
- 4AB's earnings are expected to grow with 22.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.43
PEG (5Y)N/A
EPS Next 2Y28.14%
EPS Next 3Y22.01%
5. 4AB.DE Dividend Analysis
5.1 Amount
- 4AB has a Yearly Dividend Yield of 3.30%. Purely for dividend investing, there may be better candidates out there.
- 4AB's Dividend Yield is rather good when compared to the industry average which is at 0.63. 4AB pays more dividend than 97.47% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.89, 4AB pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.3% |
5.2 History
- The dividend of 4AB is nicely growing with an annual growth rate of 6.76%!
Dividend Growth(5Y)6.76%
Div Incr Years5
Div Non Decr Years5
5.3 Sustainability
- 4AB pays out 278.48% of its income as dividend. This is not a sustainable payout ratio.
- The dividend of 4AB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP278.48%
EPS Next 2Y28.14%
EPS Next 3Y22.01%
4AB.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:4AB (4/8/2026, 7:00:00 PM)
180.25
+5.4 (+3.09%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-04 2026-02-04/bmo
Earnings (Next)04-29 2026-04-29/bmo
Inst Owners76.17%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap318.71B
Revenue(TTM)61.16B
Net Income(TTM)4.19B
Analysts77.95
Price Target216.59 (20.16%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.3% |
Yearly Dividend5.73
Dividend Growth(5Y)6.76%
DP278.48%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.46%
Min EPS beat(2)0.18%
Max EPS beat(2)2.75%
EPS beat(4)4
Avg EPS beat(4)1.25%
Min EPS beat(4)0.18%
Max EPS beat(4)2.75%
EPS beat(8)8
Avg EPS beat(8)1.12%
EPS beat(12)10
Avg EPS beat(12)0.74%
EPS beat(16)12
Avg EPS beat(16)0.58%
Revenue beat(2)0
Avg Revenue beat(2)-0.79%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)-0.78%
Revenue beat(4)2
Avg Revenue beat(4)0.07%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.21%
Revenue beat(12)5
Avg Revenue beat(12)0.03%
Revenue beat(16)5
Avg Revenue beat(16)-0.64%
PT rev (1m)0%
PT rev (3m)1.71%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.62%
EPS NY rev (1m)0%
EPS NY rev (3m)2.1%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)-1.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.49%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.84 | ||
| Fwd PE | 14.04 | ||
| P/S | 6.02 | ||
| P/FCF | 20.67 | ||
| P/OCF | 19.36 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.34 |
EPS(TTM)8.65
EY4.8%
EPS(NY)12.84
Fwd EY7.12%
FCF(TTM)8.72
FCFY4.84%
OCF(TTM)9.31
OCFY5.17%
SpS29.93
BVpS-1.6
TBVpS-44.8
PEG (NY)0.43
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.12% | ||
| ROE | N/A | ||
| ROCE | 23.09% | ||
| ROIC | 14.42% | ||
| ROICexc | 15.28% | ||
| ROICexgc | N/A | ||
| OM | 34.23% | ||
| PM (TTM) | 6.84% | ||
| GM | 71.62% | ||
| FCFM | 29.13% |
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
ROICexc(3y)13.19%
ROICexc(5y)12.96%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.1%
ROCE(5y)18.64%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y5.79%
ROICexc growth 5Y14.56%
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
F-Score8
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.79 | ||
| Debt/EBITDA | 2.11 | ||
| Cap/Depr | 14.92% | ||
| Cap/Sales | 1.98% | ||
| Interest Coverage | 6.97 | ||
| Cash Conversion | 65.45% | ||
| Profit Quality | 425.61% | ||
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.56 | ||
| Altman-Z | 2.25 |
F-Score8
WACC8.64%
ROIC/WACC1.67
Cap/Depr(3y)11.82%
Cap/Depr(5y)10.58%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.55%
Profit Quality(3y)434.7%
Profit Quality(5y)340.33%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
EPS Next Y48.4%
EPS Next 2Y28.14%
EPS Next 3Y22.01%
EPS Next 5Y15.08%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%
Revenue Next Year10.06%
Revenue Next 2Y9.09%
Revenue Next 3Y8.46%
Revenue Next 5Y6.43%
EBIT growth 1Y26.92%
EBIT growth 3Y1.33%
EBIT growth 5Y8.87%
EBIT Next Year42.07%
EBIT Next 3Y19.5%
EBIT Next 5Y10.21%
FCF growth 1Y-0.09%
FCF growth 3Y-9.76%
FCF growth 5Y1.19%
OCF growth 1Y1.19%
OCF growth 3Y-8.62%
OCF growth 5Y1.59%
ABBVIE INC / 4AB.DE Fundamental Analysis FAQ
What is the ChartMill fundamental rating of ABBVIE INC (4AB.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to 4AB.DE.
What is the valuation status for 4AB stock?
ChartMill assigns a valuation rating of 8 / 10 to ABBVIE INC (4AB.DE). This can be considered as Undervalued.
Can you provide the profitability details for ABBVIE INC?
ABBVIE INC (4AB.DE) has a profitability rating of 7 / 10.
How financially healthy is ABBVIE INC?
The financial health rating of ABBVIE INC (4AB.DE) is 3 / 10.
What is the earnings growth outlook for ABBVIE INC?
The Earnings per Share (EPS) of ABBVIE INC (4AB.DE) is expected to grow by 48.4% in the next year.